Tag: software
-
Infographic – Smart Home Technologies Emerge
While these systems promise a more connected, efficient, and pleasant home, they require continued development of underlying basic technologies.
-
Infographic – Apple Dominates Smart Watch Sales
According to Counterpoint Research, three in 10 new devices shipped in 2021 (30%) were made by Apple, with Samsung a distant second at 10 percent.
-
Industry-Univ. Team Assessing Electronic Brain Biomarkers
A developer of software analyzing brain signals for neurological disease indicators is engaging medical researchers to help assess the software in real-world settings.
-
Trial to Test Smart Watch to Guide Blood Thinners
A clinical trial is planned to test heart rhythms measured with an Apple smart watch to guide use of blood thinning medicines in people with irregular heartbeat.
-
AI Recreates Tumor Environment for Precision Cancer Care
A bioinformatics company designed an algorithm that digitally recreates the support network for tumors from RNA sequences, to guide precise treatments for cancer patients.
-
Biotechs Discover Antimicrobial Peptide for Food Safety
Two biotechnology companies say they discovered a peptide molecule with antimicrobial properties for faster identification and containment of food contamination outbreaks.
-
Ginkgo Acquires Biomaterials Maker as Industry Consolidates
A developer of synthetic biology tools and components is acquiring a biological materials developer for its automation assets as the biotechnology industry consolidates.
-
Infographic – Digital Health Keeps Clicking in 2022
While venture capital funding for digital health start-ups worldwide is down compared to last year, the pace so far in 2022 remains on an historically strong track.
-
Smell Detection Tech Company Raises $4M in Seed Funds
A start-up biotechnology company creating a system that translates an animal’s sense of smell into electronic signals is raising $4 million in seed equity funds.
-
Cancer Nutrition Therapy Biotech Raises $47M in Early Funds
A start-up company developing nutritional therapies to attack precise molecular cancer targets is raising $47 million in its first venture funding round.